
    
      At week 12 subjects not on oral corticosteroids (OCS) will complete the treatment period and
      return after 4 weeks for final follow up visit. Those subjects who were taking OCS at
      baseline will continue for a maximum of 12 additional weeks, double blind period during which
      their current OCS treatment will be titrated down according to their clinical response.
    
  